Dr Andrew Appello, LAC, APN in Skillman, NJ - Acupuncturist

Dr Andrew Appello, LAC, APN is a Acupuncturist based in Skillman, New Jersey. Dr Andrew Appello is licensed to practice in New Jersey (license number 25MZ00055600) and his current practice location is 10 Vreeland Dr Ste 103, Skillman, New Jersey. He can be reached at his office (for appointments etc.) via phone at (609) 751-2793.

NPI number for Dr Andrew Appello is 1144468893 and his current mailing address is 10 Vreeland Dr Ste 103, Skillman, New Jersey. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1144468893.

Contact Information

	Dr Andrew Appello, LAC, APN
	10 Vreeland Dr Ste 103, Skillman, NJ 08558-2620
	(609) 751-2793
	Not Available

Provider's Profile

Full Name	Dr Andrew Appello
Gender	Male
Speciality	Acupuncturist
Location	10 Vreeland Dr Ste 103, Skillman, New Jersey
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1144468893
Provider Enumeration Date: 02/02/2009
Last Update Date: 05/18/2021

Medical Identifiers

Medical identifiers for Dr Andrew Appello such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1144468893	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
163W00000X	Registered Nurse	26NR16752400 (New Jersey)	Secondary
363LF0000X	Nurse Practitioner - Family	26NJ00983300 (New Jersey)	Secondary
171100000X	Acupuncturist	25MZ00055600 (New Jersey)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Andrew Appello is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Andrew Appello, LAC, APN 10 Vreeland Dr Ste 103, Skillman, NJ 08558-2620 Ph: (609) 751-2793	Dr Andrew Appello, LAC, APN 10 Vreeland Dr Ste 103, Skillman, NJ 08558-2620 Ph: (609) 751-2793

News Archive

How can we predict the number of future COVID-19 hospital admissions?

Research led by Sophie Meakin of the London School of Hygiene & Tropical Medicine in the United Kingdom suggests ensemble forecasts — a method combining multiple models to predict COVID-19 cases — may be more accurate in estimating COVID-19 hospital admissions in local areas.

U.S. Patent Office issues Notice of Allowance to Biomoda's CyPath assay for cancer detection

Cancer diagnostics company Biomoda, Inc. received Notice of Allowance for a U.S. Patent application on a quantitative method for scoring cells labeled with the CyPath assay to determine whether cells are dysplastic or carcinomic by measuring the photon emission rate.

Study examines treatment options for children diagnosed with ADHD

For doctors and parents to jointly decide how to attack pediatric conditions, such as attention-deficit/hyperactivity disorder (ADHD), practical barriers to recommended health treatments need to be overcome, according to a study by The Children's Hospital of Philadelphia. In considering their options, parents preferred their physicians to offer an unbiased presentation of all available treatments.

Teva presents new Reslizumab data at European Respiratory Society (ERS) International Congress 2015

Teva Pharmaceutical Industries Ltd., has presented results from a post hoc analysis of two pivotal Phase III clinical trials showing that treatment with reslizumab reduced clinical asthma exacerbations (CAEs) by 75 percent versus placebo in a subgroup of patients with late onset asthma (diagnosed at 40 years of age and older) with elevated blood eosinophils, who were inadequately controlled on inhaled corticosteroids (ICS).

Researchers test whether estrogen could improve outcomes after traumatic brain injury, shock

UT Southwestern Medical Center researchers are conducting two pilot clinical trials to determine whether a single, early dose of estrogen can improve survival and neurological outcomes after severe traumatic brain injury or traumatic hemorrhagic shock.

Dr Andrew Appello, LAC, APN - Acupuncturist in Skillman, NJ